Hinge Health (NYSE:HNGE) Shares Gap Down – What’s Next?

Hinge Health Inc. (NYSE:HNGE) gapped down before the market opened on Wednesday . The stock had previously closed at $53.44, but opened at $47.86. Hinge Health shares last traded at $47.97, with a volume of 1,309,933 shares.

Analysts Set New Price Targets

HNGE has been the topic of several analyst reports. Citizens Jmp began coverage on shares of Hinge Health in a report on Monday, July 14th. They set a “strong-buy” rating and a $58.00 price target on the stock. Robert W. Baird started coverage on Hinge Health in a research note on Friday, September 5th. They issued a “neutral” rating and a $56.00 price target for the company. Stifel Nicolaus upped their price objective on Hinge Health from $63.00 to $66.00 and gave the stock a “buy” rating in a research note on Thursday, September 11th. Evercore ISI increased their target price on Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Finally, Barclays boosted their price target on Hinge Health from $62.00 to $65.00 and gave the stock an “overweight” rating in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Hinge Health presently has a consensus rating of “Moderate Buy” and an average target price of $59.93.

Hinge Health Stock Up 0.9%

The company has a fifty day moving average price of $52.43.

Hinge Health (NYSE:HNGE) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.18. The firm had revenue of $154.21 million for the quarter, compared to analysts’ expectations of $142.44 million. The business’s revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hedge Funds Weigh In On Hinge Health

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of Hinge Health by 22.6% in the 3rd quarter. Vanguard Group Inc. now owns 1,237,839 shares of the company’s stock worth $60,753,000 after buying an additional 228,234 shares in the last quarter. Cibc World Market Inc. bought a new position in shares of Hinge Health in the 3rd quarter valued at about $310,000. Jones Financial Companies Lllp grew its position in Hinge Health by 348.0% in the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock worth $54,000 after acquiring an additional 870 shares in the last quarter. Flaharty Asset Management LLC bought a new stake in Hinge Health during the third quarter worth approximately $294,000. Finally, Lisanti Capital Growth LLC raised its position in Hinge Health by 2.0% during the third quarter. Lisanti Capital Growth LLC now owns 60,911 shares of the company’s stock valued at $2,990,000 after purchasing an additional 1,211 shares during the period.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.